The European Medicines Agency is working on an initiative to establish a common protocol, or a minimum set of requirements, for registries for CAR-T cells that are regulated as advanced therapy medicinal products (ATMPs) in the EU.
The initiative will include the EMA hosting a registries workshop that will result in a report "summarising the discussions of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?